Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REPRISE Japan: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Clinical Evaluation in Japan

NCT02491255 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02491255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02491255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REPRISE Japan: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Clinical Evaluation in Japan
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
June 22, 2015
Completion date
September 13, 2021
Enrollment
70 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis